Peroxiredoxin-2 represses NRAS-mutated melanoma cells invasion by modulating EMT markers
Open Access
- 1 July 2024
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 177, 116953
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA83115)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (142058/2020-3)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (304339/2017-2)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (408769/2018)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (309440/2021-1)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação de Amparo à Pesquisa do Estado de São Paulo (17/04926-6)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (18/14936-1)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (20/15042-4)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (22/08041-7)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (20/14019-9)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (22/09245-5)
This publication has 34 references indexed in Scilit:
- The progressive relationship between increasing Breslow thickness and decreasing survival is lost in patients with ultrathick melanomas (≥15 mm in thickness)Journal of the American Academy of Dermatology, 2022
- NRAS mutant melanoma: Towards better therapiesCancer Treatment Reviews, 2021
- Epithelial-Mesenchymal Transition in Cancer: A Historical OverviewTranslational Oncology, 2020
- The crucial role of ZEB2: From development to epithelial‐to‐mesenchymal transition and cancer complexityJournal of Cellular Physiology, 2019
- microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cellsCellular Oncology, 2016
- Treatment of NRAS-Mutant MelanomaCurrent Treatment Options in Oncology, 2015
- Proteomics study of open biopsy samples identifies peroxiredoxin 2 as a predictive biomarker of response to induction chemotherapy in osteosarcomaJournal of Proteomics, 2013
- Discovery of gliotoxin as a new small molecule targeting thioredoxin redox systemBiochemical and Biophysical Research Communications, 2007
- 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implicationsTrends in Molecular Medicine, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001